Business · 19/08/2019Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Nonprescription Drugs Advisory Committee for Regulatory Feedback
Summary
The Food and Drug Administration (FDA) is hosting a public meeting of the Nonprescription Drugs Advisory Committee to gather input on regulatory matters, with a public docket open for comments on the proposed changes
Original source language: Federal Register — Food and Drug AdministrationOpen original release →